Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles

Table 2 Comparison of clinical features between patients with chronic active hepatitis C virus G1b infection (active hepatitis C virus) and cleared hepatitis C virus infection (Sustained virological response)

	Active HCV (n = 82)				SVR (n = 91)				P value
	n (%)	Median	Q1	Q3	n (%)	Median	Q1	Q3
Discrete traits
Sex									0.500
Male	36 (44)				46 (51)
Female	46 (56)				45 (49)
Quantitative traits
Age (yr)		69.0	63.0	74.8		65.0	57.0	73.0	0.048
BMI (kg/m2)		21.9	20.3	24.0		22.5	21.0	24.5	0.145
HbA1c (%)		5.5	5.2	5.8		5.6	5.4	6.0	0.105
Glucose (mg/dL)		105.0	95.0	117.0		104.0	95.0	114.5	0.800
AST (IU/L)		41.0	30.0	74.3		23.0	20.0	28.0	< 0.001
ALT (IU/L)		36.5	24.8	58.5		17.0	13.0	23.0	< 0.001
Total bilirubin (mg/dL)		0.7	0.6	0.9		0.7	0.5	0.8	0.040
γ-GTP (IU/L)		30.5	21.0	52.8		21.0	16.0	30.0	< 0.001
Albumin (g/dL)		4.2	3.8	4.3		4.4	4.2	4.6	< 0.001
Platelet (104/μL)		15.5	11.8	20.6		17.3	13.4	21.0	0.048
Lipid profiles
Total cholesterol (mg/dL)		174.5	151.3	192.8		193.0	175.5	216.5	< 0.001
Triglyceride (mg/dL)		89.5	64.0	116.8		88.0	68.0	135.0	0.700
LDL cholesterol (mg/dL)		93.5	77.0	110.5		112.5	93.0	133.5	< 0.001
HDL cholesterol (mg/dL)		59.8	47.3	72.2		61.7	51.2	74.0	0.195

HCV: Hepatitis C virus; SVR: Sustained virological response; BMI: Body mass index; AST: Aspartate 2-oxoglutarate aminotransferase; ALT: Alanine 2-oxoglutarate aminotransferase; γ-GTP: γ-Glutamyl transpeptidase; LDL: Low-density lipoprotein; HDL: High-density lipoprotein.